Clinical Analysis of Anti-NMDAR Encephalitis Combined with MOG Antibody in Children
Authors:
Preprint
- 12 November 2019
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective: To analyze the clinical features in children with anti-NMDAR encephalitis combined with myelin oligodendrocyte glycoprotein antibody (MOG ab).Methods: Clinical data of 7 children with anti-NMDAR encephalitis combined with MOG ab were collected in Guangzhou Women and Children’s Medical Center from January, 2016 to June, 2019.Results: Average onset age was 6.0±1.3 year-old, male to female was 2:5. Prominent symptoms in anti-NMDAR encephalitis were abnormal mental behavior (7/7), sleep disorder (6/7) and speech disorder (6/7), while in MOG ab related encephalomyelitis were encephalopathy (5/7) and paralysis (4/7). 1 case developed anti-NMDAR encephalitis 1 year after recovery from MOG ab related acute disseminated encephalomyelitis (ADEM). 4 cases developed anti-NMDAR encephalitis and MOG ab related ADEM simultaneously, with 2 cases relapsed. 2 cases were anti-NMDAR encephalitis with only MOG ab positive. 10 MRI examinations were performed in acute stage. 8/10 brain MRI showed abnormalities with multiple demyelinating lesions mainly involve subcortical white matter (7/8), cortex (6/8) and basal ganglia (5/8). 2/10 had long segment myelitis. Patients improved significantly after corticosteroid and intravenous immunoglobulin (IVIG) treatment. Patients with recurrent course (n=2) had higher MOG ab titer (1:320) and longer duration (≥12 months) compared with non-recurrent course (n=5), MOG antibody(≤1:100) (≤6 months). 3 Cases had neurological sequelae with higher cerebrospinal fluid (CSF) NMDAR antibody titer at first onset (1:320). 2 had emotional problems and 1 had epilepsy.Conclusion: Children with anti-NMDAR encephalitis combined with MOG ab were more common in girls around 6 year-old. Patients responded well to Corticosteroid and IVIG. Cases with persistent MOG ab need longer follow-up due to recurrent risk, high titer of CSF NMDAR antibody may cause neurological sequelae. Keywords: anti-NMDAR encephalitis, myelin oligodendrocyte glycoprotein antibody, childrenKeywords
All Related Versions
- Published version: Multiple Sclerosis and Related Disorders, 42, 102018.
This publication has 16 references indexed in Scilit:
- Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort studyBrain and Development, 2019
- A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodiesJournal of Neuroimmunology, 2019
- Neurological update: MOG antibody diseaseJournal of Neurology, 2018
- An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitisJournal of Neuroimmunology, 2018
- Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology, 2018
- Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitisMultiple Sclerosis and Related Disorders, 2018
- Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodiesMultiple Sclerosis and Related Disorders, 2017
- Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature reviewClinical Neurology and Neurosurgery, 2017
- Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitisAnnals of Neurology, 2014
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007